Tiziana Life Sciences Share Discussion Threads

[fandagle] 28/5/2022 07:43

Can we all agree now that this has been a ponsy scam?

[twodegrees] 27/4/2022 14:15

ACCUSTEM SCIENCES - Notification of Receipt of Entitlements
Acquisition by Accustem Sciences Inc (US Accustem).

1 New share of US Accustem Common stock for every Existing 20 shares of Accustem Sciences Ltd (UK Accustem) Ordinary shares held.

Based on your holding of 1758 ACCUSTEM SCIENCES ORD GBP0.01 shares you have received 87 ACCUSTEM SCIENCE.I USD0.001 shares.

On 2nd November 2021 the board of directors of UK Accustem announced a proposal to establish US Accustem as the holding company of the Accustem Group.

The Acquisition, which was conducted by way of a Scheme of Arrangement, received shareholder approval at a General Meeting and Court approval at a Court Meeting both held on 18th November 2021. The Scheme was then Court sanctioned at a Court Hearing held on 25th November 2021 and subsequently became effective on 29th November 2021.

We can confirm that the New US Accustem shares have now been credited to your account and your Existing UK Accustem shares have been removed.

No fractions of shares have been issued. Any resulting cash entitlements will be dealt with in accordance with our Terms & Conditions.

Please be aware that the New US Accustem shares have been admitted to trading on the US OTC Market. As a result we will only be able to facilitate sales in the US Accustem shares via our sharedealing facility.

Should you wish to find more information about the Scheme, please visit the Company website, www.accustem.com/

[jpuff] 27/4/2022 09:39

Riley Financial Sticks to Their Buy Rating for Tiziana Life Sciences (TLSA)Source: TipRanksB.Riley Financial analyst Mayank Mamtani maintained a Buy rating on Tiziana Life Sciences (TLSA – Research Report) today and set a price target of $3.00. The company's shares closed last Wednesday at $1.04. According to TipRanks.com, Mamtani is ranked 0 out of 5 stars with an average return of -21.8% and a 28.5% success rate. Mamtani covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Spectrum Pharmaceuticals, and Madrigal Pharmaceuticals. Currently, the analyst consensus on Tiziana Life Sciences is a Moderate Buy with an average price target of $3.00.https://www.tipranks.com/news/blurbs/b-riley-financial-sticks-to-their-buy-rating-for-tiziana-life-sciences-tlsa?utm_source=advfn.com&utm_medium=referral

[jpuff] 27/4/2022 09:30

Enjoy the Fireside chat laddie

[fandagle] 27/4/2022 08:45

Good Grief Is this TaT still trading?

[jpuff] 26/4/2022 18:34

Yes and the ticker is tlsa over on the Nasdaq. Not to be confused with the slightly larger company ticker tsla which is Tesla.

[breezy4] 26/4/2022 18:17

Is this trading??

[jpuff] 26/4/2022 17:37

Had an email from Tiziana to say they're partaking in a fireside chat. Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

[alancapone] 26/4/2022 06:33

"The stock market is a device for transferring money from the impatient to the patient."

[marshsi] 25/4/2022 23:57

Sold out of this scam today.
Put it behind me.
Complete sham.
Still left with a piece of paper with ACUT shares on. Broker won’t touch it.

[nerdofsteel] 14/4/2022 16:03

LONDON and PHOENIX, April 14, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, is pleased to announce its uplisting from the OTC Pink Sheets to the OTCQB® Venture Marketplace (the “OTCQB”). AccuStem will commence trading on the OTCQB at the market open today, April 14, 2022, under the ticker “ACUT.” The Company believes that the uplist will create greater visibility to retail and institutional investors, as well as further enhance trading liquidity.

[one_frankel] 11/4/2022 19:39

1Macosta, when you're emailing either party, CC the other so they're aware of the situation at hand and will hopefully be able to resolve it with the joint effort.

[stenick] 05/4/2022 13:33

hxxps://www.tizianalifesciences.com/news-item?s=2022-04-05-fda-grants-permission-to-enroll-up-to-8-additional-secondary-progressive-multiple-sclerosis-spms-patients-in-the-expanded-access-program-with-intranasal-foralumab

Proof building up. Alzheimer’s next.

[jpuff] 02/4/2022 06:51

You can complain to the financial ombudsman and get them to try and sort it

[1macosta] 01/4/2022 16:08

Hi all. I need some advice and I hope this is the place to get some help. I have my TILS shares in Barclays stockbrokers and they are quite simply useless in giving me my share certificate. I spoke with a lady at Tiziana (contact details on the Tiziana website) and she told me Barclays are ignoring her requests and not replying. She said a few investors with tils in barclays are having the same problem. I have contacted Barclays and they say it's Tiziana who doesn't reply to their requests. Any advice would be much appreciated. Also if I eventually get my share certificate from Barclays, what will be the best broker to contact? Thank you in advance.

[jpuff] 25/3/2022 19:22

There's plenty of liquidity providing you haven't got squillions of them!

[marshsi] 24/3/2022 16:29

First direct

Said there was no liquidity to sell

[jpuff] 24/3/2022 16:26

You need a decent broker

[michelle74] 23/3/2022 21:00

Yes I agree

[jpuff] 23/3/2022 20:10

The secret is in the long term. Don't get tempted by a few pennies

[michelle74] 23/3/2022 18:13

Yes I have it's looking good hopefully will recover all my money

[twodegrees] 23/3/2022 16:10

up to 1 dollar 35 does anyone still have these?